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Edited by M. ZhangAbstractIntegrins are a family of heterodimeric (α+β) adhesion receptors that play key roles in many cellular processes.
Integrins are unusual in that their functions can be modulated from both outside and inside the cell. Inside-out
signaling is mediated by binding adaptor proteins to the flexible cytoplasmic tails of the α- and β-integrin
subunits. Talin is one well-known intracellular activator, but various other adaptors bind to integrin tails,
including 14-3-3-ζ, a member of the 14-3-3 family of dimeric proteins that have a preference for binding
phosphorylated sequence motifs. Phosphorylation of a threonine in the β2 integrin tail has been shown to
modulate β2/14-3-3-ζ interactions, and recently, the α4 integrin tail was reported to bind to 14-3-3-ζ and
associate with paxillin in a ternary complex that is regulated by serine phosphorylation.
Here, we use a range of biophysical techniques to characterize interactions between 14-3-3-ζ and the
cytoplasmic tails of α4, β1, β2 and β3 integrins. The X-ray structure of the 14-3-3-ζ/α4 complex indicates a
canonical binding mode for the α4 phospho-peptide, but unexpected features are also observed: residues
outside the consensus 14-3-3-ζ bindingmotif are shown to be essential for an efficient interaction; in contrast, a
short β2 phospho-peptide is sufficient for high-affinity binding to 14-3-3-ζ. In addition, we report novel 14-3-3-ζ/
integrin tail interactions that are independent of phosphorylation. Of the integrin tails studied, the strongest
interaction with 14-3-3-ζ is observed for the β1A variant. In summary, new insights about 14-3-3-ζ/integrin tail
interactions that have implications for the role of these molecular associations in cells are described.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.Introduction
Integrins are membrane-spanning heterodimeric
receptors, associated with a wide-range of normal
functions, including cell adhesion, migration and
differentiation, as well as disease.1,2 They are
formed by α- and β-subunits composed of large
extracellular (ecto) domains, a transmembrane do-
main and a usually short (13–70 residues) C-terminal
cytoplasmic domain.3 The C-terminal domains are
flexible “tails” that act as hubs for numerous protein–
protein interactions4–6 that control various inside-
to-outside and outside-to-inside signals. To date,
knowledge of interacting partners and regulatory
mechanisms is more advanced for β-integrin than
for α-integrin tails. Characterized β-integrin tail
binding proteins include talin,7,8 kindlin,9,10 filamin11
and 14-3-3.12
The 14-3-3 family consists of highly conserved
acidic proteins of ~30 kDa molecular size that are
expressed in all eukaryotic cells. In humans, seven0022-2836 © 2013 The Authors. Published by Elsevier Ltd.Open access udistinct 14-3-3 isoforms (β, γ, ε, η,σ, τ and ζ) havebeen
described, all of which form homodimers or hetero-
dimers. They are involved in the regulation of many
signaling pathways, including cell cycle progression,
programmed cell death and cytoskeletal dynamics.
The family is also associated with a number of human
diseases, such as cancer and neurological dis-
orders.13,14 14-3-3 proteins were initially described
as phosphor-serine/threonine binding modules with
two consensus recognition motifs, classified as
binding “mode-1” (RSXpSXP) and “mode-2” (RXF/
YXpSXP).15 Subsequently, divergent binding modes
have been described including affinity to unpho-
sphorylated motifs.16,17 X-ray structures of numerous
14-3-3 isoforms and complexes have revealed con-
siderable detail about the various binding modes.18,19
Recently, the structure of 14-3-3-ζ in complex with
a phosphorylated peptide from the β2 integrin tail
was determined.20 Another study linked 14-3-3-β
with β1 and β3 integrins, but no structural details
were provided.21 An association between 14-3-3-ζJ. Mol. Biol. (2013) 425, 3060–3072nder CC BY license.
306114-3-3-ζ Interactions with Integrin Tailsand α4 was recently reported by Deakin et al.,22
and evidence was presented for a ternary complex
with 14-3-3-ζ/α4 and paxillin, a focal adhesion
protein that serves as a platform for the binding of
numerous proteins.23 In addition, previous studies
suggested that an association between paxillin andFig. 1. NMR studies of the α4/14-3-3-ζ interaction. (a) 15N–
S1011D (right) in black and after the addition of unlabeled 0.1
close-up of the α4 wt spectrum below, resonances correspon
indicated in circles and the phosphorylatable serine is highligh
absence (Io) of 14-3-3-ζ of α4 resonances shown in (a) for the
were calculated using the CCPN Analysis software. The substhe α4 integrin tail is essential for regulating cell
migration.24–26 It was proposed that this interaction
is stabilized by 14-3-3-ζ in a ternary complex that
accelerates cell migration.22 The binding of 14-3-3-ζ
to α4 was also observed to depend on phosphor-
ylation of α4 serine 1011.22,271H HSQC spectra of 15N-labeled 0.1 mM α4 wt (left) and
mM 14-3-3-ζ (overlaid in green and blue, respectively). In a
ding to the residues observed in the crystal structure are
ted in red. (b) The intensity ratio (I/Io) in the presence (I) or
wt (top) and S1011D variant (bottom). The intensity ratios
tituted serine residue is highlighted in red.
3062 14-3-3-ζ Interactions with Integrin TailsHere, we aimed to gain insight into the association
of integrin cytoplasmic tails with 14-3-3 proteins. Our
initial focus was characterizing the interaction
between the α4 integrin tail and 14-3-3-ζ. We first
solved the crystal structure of 14-3-3-ζ in complex
with a phosphorylated α4-derived peptide and
defined its binding mode. The use of complementary
techniques, particularly NMR (nuclear magnetic
resonance) and ITC (isothermal titration calorime-
try), revealed that the 14-3-3-ζ/α4 interaction is
dependent not only on phosphorylation but also on
residues outside the central 14-3-3-ζ binding motif.
We found no evidence for a ternary 14-3-3-ζ/paxillin/
α4 complex or a binary paxillin/α4 complex. We also
carried out a biophysical characterization of β-integ-
rin tail interactions with 14-3-3-ζ. All β-integrin tails
tested bound to 14-3-3-ζ in a phosphorylation-inde-
pendent manner through an epitope proximal to the
transmembrane domain. In the case of β2 integrin
tail, this region is well separated from the previously
characterized phosphorylation-dependent 14-3-3-ζ
binding site. Studies of 14-3-3-ζ variants provided
further clues about the key determinants of the
interactions.Results
14-3-3-ζ binding to the α4 integrin cytoplasmic tail
We used the α4 phospho-mimetic, S1011D, to
explore the phosphorylation dependence of 14-3-3-ζ
binding to the consensus RQYKSIL motif in the α4
tail.22 NMR-monitored titrations of 15N-labeled full-
length α4 integrin tails, wild type (wt) or S1011D, with
unlabeled 14-3-3-ζ produced changes of α4 reso-
nances. As shown in Fig. 1a, addition of 14-3-3-ζ
causes a significant decrease in α4 amide reso-
nance intensities, indicative of an interaction. TheTable 1. Integrin constructs used in experiments
Name Residue numberinga
α4 wt 1001–1032 GPLGSKAGFFK
α4 S1011D 1001–1032 GPLGSKAGFFK
α4-30pS 1003–1032 GFFKRQYK
α4-11pS 1005–1015
β2 wt 724–769 GSKALIHLSDLREYRRF
β2-45pT 724–769 KALIHLSDLREYRRFE
β2-11pT 752–762
β1A wt 752–798 GS KLLMIIHDRREFAKF
β1-11pT 783–793
β1D wt 752–801 GS KLLMIIHDRREFAKFEK
β3 wt 742–788 GS KLLITIHDRKEFAKF
β7 wt 747–798 GS RLSVEIYDRREYSRFEK
a According to Uniprot entries P13612, P05107, P05556, P05106 a
b pS and pT correspond to phospho-serine and phospho-threonine
substitutions to aspartic. Amino acids from the cloning tag in the N-ter
c R, recombinant; S, synthetic.extent of resonance intensity decrease is high
across the whole α4 sequence but is more pro-
nounced in the N-terminal region where the 14-3-3-ζ
binding motif is located (Fig. 1b). Although the
characteristics of the NMR spectra (severe broad-
ening on addition of 14-3-3-ζ) make it difficult to
extract precise information about binding affinities,
they clearly show that a specific interaction between
14-3-3-ζ and α4 exists even in the absence of
phosphorylation.
The affinities of 14-3-3-ζ/α4 interactions were
measured by ITC for the α4 wt and S1011D samples,
as well as for two synthetic peptides containing
phospho-serine residues α4-30pS and α4-11pS
(see Table 1 for peptide nomenclature). Typical
data are shown in Fig. 2a–d, and the resulting affinity
values are summarized in Fig. 2e. The α4 wt binding
to 14-3-3-ζ is relatively weak; thus, a Kd could not be
determined by ITC. However, the α4 S1011D
construct had a Kd value of approximately 60 μM,
and the affinity of the phospho-serine containing
α4-30pS was also strong (Kd ~ 24 μM). These
results are consistent with a prominent role for
phosphorylation in the regulation of 14-3-3 interac-
tions and show that the phospho-serine-to-aspartic
substitution is a suitable phospho-mimetic for the
14-3-3-ζ/α4 association. Crucially, we observed that
α4 residues outside the consensus 14-3-3 binding
motif are also necessary for efficient association, as
illustrated by the 14-3-3-ζ/α4-11pS interaction that
gave a Kd value of over 300 μM (an ~15-fold
reduction in affinity compared to α4-30pS).
Structure determination of the 14-3-3-ζ/phospho-α4
integrin tail complex
The ITC observation that α4-30pS has a relatively
high affinity led to the successful crystallization and
structure determination of a complex with 14-3-3-ζ.
Crystals were obtained in space group C2221,Sequenceb Sourcec
RQYKSILQEENRRDSWSYINSKSNDD R
RQYKDILQEENRRDSWSYINSKSNDD R
pSILQEENRRDSWSYINSKSNDD S
FKRQYKpSILQE S
EKEKLKSQWNNDNPLFKSATTTVMNPKFAES R
KEKLKSQWNNDNPLFKSApTTTVMNPKFAES S
PLFKSApTTTVM S
EKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK R
YKSAVpTTVVNP S
EKMNAKWDTQENPIYKSPINNFKNPNYGRKAGL R
EEERARAKWDTANNPLYKEATSTFTNITYRGT R
EQQQLNWKQDSNPLYKSAITTTINPRFQEADSPTL R
nd P26010.
, respectively, and are in boldface together with serine/threonine
minus of the sequence are italicized.
Fig. 2. ITC studies of the α4/14-3-3-ζ interaction. (a) ITC sensorgram of in-cell 120 μM α4 wt sample injected with
1.2 mM 14-3-3-ζ; the interaction is weak, in the millimolar range, and an accurate fit could not be obtained. (b) ITC
sensorgram of in-cell 150 μM α4 S1011D sample injected with 2.0 mM 14-3-3-ζ; thermodynamic parameters from the fit
are shown in (e). (c) ITC sensorgram of in-cell 80 μM α4-30pS phospho-peptide injected with 0.75 mM 14-3-3-ζ. (d) ITC
sensorgram of in-cell 120 μM α4-11pS phospho-peptide injected with 1.2 mM 14-3-3-ζ. (e) ITC affinity values and
thermodynamic parameters of integrin tail fragments for the 14-3-3-ζ interaction.
306314-3-3-ζ Interactions with Integrin Tailsdiffraction data were collected to 2.2 Å resolution and
the structure was solved by molecular replacement
(Table 2). Each asymmetric unit contained a single
copy of the 14-3-3-ζ/α4-30pS complex. Visible
electron density for the α4 peptide was only present
for 8 out of 30 residues (KRQYKpSIL) in the α4
peptide (Fig. 3a), suggesting a high degree of
disorder for most of the α4 sequence. This KRQYKp-
SIL peptide corresponds to a mode-2 14-3-3 binding
motif, except for the leucine in the pS + 2 position,
which is a proline in the optimal motif sequence.15
The structure has similar features to those observed
in previous 14-3-3-ζ/phospho-peptide complexes.30
The 14-3-3-ζ protein is a flat, W-shaped dimer, and
each subunit contains nine antiparallel α-helices. The
overall electrostatic surface of 14-3-3-ζ is negatively
charged, but the channel accommodating the phos-
pho-peptide has a basic pocket for the phosphate
group (Fig. 3b). The α4 integrin peptide binds in this
pocket, and the phosphate forms electrostatic in-
teractions with the conserved K49, R56 and R127
residues with an additional hydrogen bond involving
the Y128 side-chain hydroxyl (Fig. 3c). Other key
14-3-3 residues that participate in peptide binding are
illustrated in Fig. 3d.The 14-3-3-ζ/α4 complex is the second structure of
an integrin tail bound to a 14-3-3 protein, after the
previously described 14-3-3-ζ/β2-pT.20 As illustrated
in Fig. 3e, the β2 integrin peptide conforms to a
mode-1 14-3-3 binding motif with a phospho-threo-
nine whereas the α4 integrin peptide is mode-2,
featuring a phospho-serine; the arrangement of the
two peptides is otherwise similar. PISA analysis31
gives an interface area of 559.2 Å2 for the 14-3-3-ζ/
α4 complex and 449.6 Å2 for 14-3-3-ζ/β2, and an
overlay of the two complexes shows that the two
integrin peptides superimpose well, with most
residues involved in complex formation having
identical positions in the two structures (Fig. 3f).
14-3-3-ζ binding to the α4 integrin cytoplasmic
tail and paxillin
The interactions of α4 and 14-3-3-ζ with paxillin
were also investigated. The association of paxillin
with α4 has been detected using pull-down exper-
iments with glutathione S-transferase fusion
proteins22,32,33 and, very recently, by NMR in a
study that also reports the solution structure of the α4
integrin tail.34 Using a construct of the N-terminal
Table 2. Crystallographic data collection and refinement
statistics
Data collection
Beamline Diamond, I04-1
Wavelength (Å) 0.9163
Space group C2221
Cell parameters
a, b, c (Å) 89.03, 111.60, 72.99
α, β, γ (°) 90, 90, 90
Resolution (Å) 44.50–2.20 (2.32–2.20)
Total reflections 110,654 (15,795)
Unique reflections 18,798 (2725)
Rmerge 0.079 (0.394)
Completeness (%) 99.8 (100)
Multiplicity 5.9 (5.8)
I/σ(I) 9.8 (3.2)
Refinement
Rwork/Rfree (%) 19.7/23.9
RMSD from ideal values
Bonds/angles (Å/°) 0.010/1.02
Overall mean B values (Å2)
Protein 59.2
Peptide 70.3
Solvent 60.2
No. of amino acid residues
per asymmetric unit
237
No. of water molecules 121
Matthews coefficient 2.79 (solvent content, 55.93%)
MolProbity statistics
All-atom contacts: clashcore,
all atoms
1.58
Protein geometry:
poor rotamers (%)
0.50
Ramachandran plot (%)
Residues in preferred regions 98.3
Residues in allowed regions 1.7
Residues in disallowed regions 0.0
Cβ deviations greater than 0.25 Å 0
MolProbity score 0.90
Residues with bad bonds (%) 0.0
Residues with bad angles (%) 0.0
Values for the highest-resolution shell are shown in parentheses.
3064 14-3-3-ζ Interactions with Integrin Tailsregion of paxillin (residues 1–323) that included all
LD motifs (Supplementary Fig. 1a), we detected no
specific interaction with the α4 integrin tail by NMR
(Supplementary Fig. 1b) and addition of paxillin
caused no further changes in a spectrum containing
an α4/14-3-3-ζ mixture (data not shown). Similarly,
no pairwise interaction was detected by ITC (Sup-
plementary Fig. 1c and d). The possibility that a
paxillin/14-3-3-ζ association depends on phosphor-
ylation was also assessed. The ELM (eukaryotic
linear motif) server35 indicated three putative 14-3-3
binding motifs in the paxillin N-terminus; of these,
only one has been reported to be phosphorylated in
vivo36 (Supplementary Fig. 1a). A phosphorylated
peptide containing this motif (corresponding to
paxillin residues 111–128) was tested for binding to
14-3-3-ζ; however, no interaction was detected by
ITC (Supplementary Fig. 1e). Thus, our biophysical
studies do not support the direct involvement of the
paxillin N-terminus in the association of 14-3-3-ζ andα4. The recent report of paxillin binding to α4
detected by NMR used shorter paxillin fragments
than us, covering the LD2–LD4 region.34 It is
possible that, in the whole N-terminal paxillin, the
α4 interaction sites are masked, which would explain
the absence of an interaction in our studies.
Interactionstudiesof theβ2 integrin tailwith14-3-3-ζ
To gain further insight into integrin tail binding to
14-3-3-ζ, we tested the interaction of the β2 integrin
tail (residues 724–769) with 14-3-3-ζ in an analo-
gous manner to the experiments with α4. NMR 15N
heteronuclear single quantum coherence (HSQC)
experiments of unphosphorylated β2 integrin tail in
the absence or presence of 14-3-3-ζ were recorded.
Addition of 14-3-3-ζ caused selective broadening of
β2 resonances (Fig. 4a), revealing that the binding
region is mainly located in the membrane proximal
part of the integrin sequence and the last four
C-terminal residues (Fig. 4b), with essentially no
overlap with the previously described 14-3-3-ζ
binding to β2 that occurs upon phosphorylation of
T758 (Fig. 4c). This implies that the β2 integrin tail
has two distinct 14-3-3-ζ sites within its sequence.
The β2/14-3-3-ζ binding strength was also com-
pared with that of α4/14-3-3-ζ. Similar to α4 wt,
unphosphorylated β2 wt showed only a weak
interaction by ITC (Fig. 5a). To evaluate the effect of
phosphorylation on β2, we carried out ITC experi-
ments on the interaction between 14-3-3-ζ and
phosphorylated long and short β2 integrin peptides.
Kd values of 8 μM and 4 μM were obtained for
β2-45pT and β2-11pT, respectively (Figs. 2e and 5b
and c). These results show that, unlike α4, a short
14-3-3-ζ bindingmotif in the β2 integrin tail is sufficient
to give a relatively high affinity interaction and that
contributions to the affinity from flanking residues
outside the 14-3-3-ζmotif are much less significant in
the β2/14-3-3-ζ than in the α4/14-3-3-ζ interaction.
Thus, although the X-ray structures show a similar
arrangement for the two integrin peptides in the
14-3-3-ζ complexes, there are significant differences
in the binding characteristics of the two integrin tails.
Interaction studies of 14-3-3-ζ and other
β-integrin tails
Our observation that themembrane proximal region
of the β2 integrin tail can interact in a phosphorylatio-
n-independent manner with 14-3-3-ζ raises the
possibility that other β-integrin tails could behave
similarly since sequence conservation is high across
β-integrin tails in this region (Fig. 5d). In contrast,
α-integrin tail sequences aremuchmore divergent; for
example, there is no serine or threonine equivalent to
the phosphorylation site of α4 in other α-integrin tails.
Thus, studies of other α-integrin tails were not
pursued, but instead, we focused on β-integrin tails.
306514-3-3-ζ Interactions with Integrin TailsNMR 15N HSQC experiments with labeled β1A, β3
and β7 and unlabeled 14-3-3-ζ (Supplementary Fig.
2a–c) showed an intensity reduction for several
resonances upon 14-3-3-ζ addition. Mapping the
intensity changes reveals that binding occurs to β1A
and β3, primarily in the N-terminal region, in a similar
way to β2 (Supplementary Fig. 3a and b). The pattern
of resonance intensity changes is more widespread
in β7 (Supplementary Fig. 3c). Our results are
consistent with a study that detected a phosphor-
ylation-independent interaction between 14-3-3-β
and β1A by yeast two-hybrid experiments.21 That
study also showed that the β1A region containing
serine/threonine residues was dispensable for the
β1A/14-3-3-β interaction. Our NMR studies indicate
that the β1D integrin tail, which has threonine-to-
asparagine substitutions, interacts with 14-3-3-ζ in a
very similar way to β1A (Supplementary Figs. 2d and
3d).
We also explored whether the phosphorylation-
dependent 14-3-3-ζ binding site seen for β2 is
present in other β-integrin tails. As illustrated in
Fig. 3e, all β-integrin tails contain potential 14-3-3
binding motifs in their C-terminal regions. Unlike
β2-11pT, no binding of peptide β1A-11pT was
detected by ITC (data not shown) possibly because
the mode-2 14-3-3 binding motif in β1A is too
divergent from the canonical motif (apart from not
having a proline in position pS/T + 2, the β1A motif
also lacks an aromatic residue in position pS/pT-2,
having instead an alanine) (Fig. 3e). It thus appears
that the β2 integrin tail is unusual in having two
distinct non-overlapping 14-3-3-ζ binding sites.
β-Integrin tails with no phosphorylation site equiva-
lent to that in β2 (such as β1A, β1D and β7) possibly
only interact via the phosphorylation-independent
binding mode.
Fluorescence polarization was used to compare the
binding of different integrin tails to 14-3-3-ζ. Fluores-
cently labeledβ1A,β3 andα4 integrin tailswere titrated
with increasing amounts of 14-3-3-ζ. As shown in
Fig. 6a, a stronger interaction was observed between
14-3-3-ζ and β1A thanwith β3 or α4. These differences
in affinity were later confirmed using ITC, where β1A
shows a significantly stronger binding, with
Kd ~ 280 μM, than β2, β3 and α4 (Figs. 2b and 6b–d).
Specificity of 14-3-3-ζ/β1A integrin tail interaction
To gain further insight into the β1A/14-3-3-ζ
association, we investigated the effects of 14-3-3-ζ
substitutions on binding to β1A integrin tail. It has
been reported that the substitution S58A in 14-3-3-β
abolishes the β1A interaction.38 S58 regulates the
dimeric state of 14-3-3,39 but it is not involved
directly in binding to phospho-peptides. The binding
of 14-3-3-ζ variants S58A and S58E to labeled β1A
was studied using NMR. As shown in Supplemen-
tary Fig. 4, there is significant reduction in β1Aresonance intensity change with the S58A variant
compared to the wt; the intensities change even less
with the S58E variant. A similar result was obtained
with the β2 integrin tail (data not shown). These
results confirm that S58 is an important residue for
β-integrin tail interactions, either directly by partici-
pating in the binding or indirectly by abrogating the
dimeric 14-3-3 state, thus explaining how phos-
phorylation of S58 could regulate these interactions.
Note that there were technical difficulties in making
some of these measurements of weak affinity in-
teractions. Some ITC measurements were limited by
protein solubility. The NMR experiments, often one of
the best ways of analyzing weak interactions, were
limited because the exchange regime was often in the
intermediate range, giving broad lines. The combined
results of the ITC, NMR and fluorescence results were,
however, all gave consistent relative values and results.Discussion
The interaction between the α4 integrin tail and
14-3-3-ζ has been characterized here using a range
of biophysical techniques. The crystal structure of
the phosphorylated α4/14-3-3-ζ complex shows that
the α4 residues around the pS bind to 14-3-3-ζ in a
mode similar to other 14-3-3-ζ/phospho-peptide
complexes. Specific interactions for both unpho-
sphorylated and a phospho-mimetic form of the α4
integrin tail with 14-3-3-ζ were detected by NMR, but
ITC affinity measurements revealed that the 14-3-3-ζ
interaction with unphosphorylated α4 integrin tail is
much weaker than that with the phosphorylated
forms. Residues outside the phosphorylated binding
motif make important contributions to the interaction
since binding of a short phosphorylated α4 integrin
peptide is weak compared to a longer one.
The characteristics of the 14-3-3-ζ/α4 interaction
reported here fit well with the hypothesis for 14-3-3/
ligand complexes described by Yang et al. that
involves primary and secondary interactions.40
Primary interactions involve contacts with residues
around the phosphate group of the target protein
associated with mode-1 and mode-2 binding motifs;
secondary interactions are phosphorylation inde-
pendent but crucial for ligand specificity.41 Our
results suggest that significant secondary interac-
tions occur in the 14-3-3-ζ/α4 complex. Only the
primary interactions were observed in the X-ray
structure with the secondary interactions presum-
ably too dynamic to observe in the crystal.
Comparison of the published 14-3-3-ζ/β2 structure
with our 14-3-3-ζ/α4 complex revealed similar
peptide binding modes; however, the observation
of phosphorylation-independent interactions for the
α4 integrin tail and the importance of residues
outside the 14-3-3 motif led us to further explore
3066 14-3-3-ζ Interactions with Integrin Tailsthe 14-3-3-ζ/β2 interaction. A phosphorylation-inde-
pendent interaction was found for β2 as well, and it
was mapped to a location distinct from the phos-
phorylation-dependent 14-3-3-ζ binding region of
that integrin tail.20 As in α4, this phosphorylation-
independent interaction is much weaker than thatFig. 3 (legend omediated by the β2 phosphorylation site. However,
the short phosphorylated binding motif in the β2
integrin tail has much higher affinity for 14-3-3-ζ than
the corresponding α4 motif. While residues outside
the 14-3-3 binding motif are important for an efficient
i n t e r a c t i o n i n α4 , s ho r t a nd l o ng β2n next page)
Fig. 4. NMR titrations between β2 wt and 14-3-3-ζ. (a) 15N–1H HSQC spectrum of 15N-labeled 0.1 mM β2 wt in the absence
(black) and presence of an equimolar amount of unlabeled 14-3-3-ζ (light pink). (b) The intensity of β2 integrin tail resonances
observed in (a) plotted as the intensity ratio (I/Io) in the presence (I) and absence (Io) of 14-3-3-ζ. (c) Amino acid sequence of the
β2 integrin cytoplasmic domain with the two 14-3-3-ζ binding sites for the phosphorylation-independent (green) and
phosphorylation-dependent (red) sites denoted. The phosphorylatable T758 is shown in bigger font size and underlined.
306714-3-3-ζ Interactions with Integrin Tailsphospho-peptides associated to 14-3-3-ζ with virtu-
ally the same affinity. These different requirements
for flanking residues could arise from cooperative
effects for the α4 interaction, not present in the β2
case.
The NMR interaction studies were extended to
β1A, β3, β7 and β1D; these indicated that 14-3-3-ζ
binds all of these in a phosphorylation-independentFig. 3. Details of the 14-3-3-ζ/α4 phospho-peptide interaction
modes. (a) Electron density omit map (2Fo − Fc) of the α4 peptid
annealing refinement in PHENIX28 after excluding the peptide a
(b) Representation of the electrostatic potential on the solvent-a
pocket where the peptide phosphate group is accommod
representation, with the phosphate group in orange. The electro
plug-in in PyMOL with chosen values of electrostatic potential
contacts between the phosphate group from the α4 peptide
additional hydrogen bondswith Y128 andR1007 from the peptid
light pink, the residues that bind the peptide phosphate group a
green. (d) Representation of the main 14-3-3-ζ residues (in gra
with the peptide. Hydrogen bonds are represented by broke
(e) Alignment of integrin tail sequences showing the regions wi
14-3-3 mode-I and mode-II binding motifs. (f) Superimposition
the structure presented here and Protein Data Bank 2V7D,20 r
Some side chains of 14-3-3 residues important for the bindin
different orientations in the two complexes and is colored to mmanner. In β1, β2 and β3 integrin tails, the binding
involves a stretch of 15–20 residues in the mem-
brane proximal part. All these interactions were
found to be very weak, but the β1A/14-3-3-ζ
association was found to be significantly stronger
than for other β-integrin tails.
Numerous regulated protein–protein interactions
are essential in a functioning cell. Many of theseand comparison of the 14-3-3-ζ/α4 and 14-3-3-ζ/β2 binding
e region at σ = 2. Themap was calculated using simulated
nd nearby atoms of 14-3-3-ζ. Peptide residues are labeled.
ccessible surface of a 14-3-3-ζmonomer showing the basic
ated. The α4 peptide is shown in green ball-and-stick
static surface was generated by the APBS software29 as a
of ±5 kT/e for the representation. (c) Representation of the
and the conserved basic pocket K49-R56-R127. The two
e are also shown. Themain chain of 14-3-3-ζ is displayed in
re displayed in gray and the α4 peptide chain is displayed in
y) other than those in the basic pocket that make contacts
n lines. Peptide residues are also represented, in green.
th reported (α4 and β2)20,22 or putative (other integrin tails)
of the α4 (in green) and β2 (in black) integrin peptides from
espectively; the phosphate groups are indicated in orange.
g are also displayed in gray, except for E180, which has
atch the corresponding integrin peptide.
Fig. 5. ITC of β2 phospho-peptide interactions with 14-3-3-ζ and sequence alignment of β-integrin tails. (a) ITC
sensorgram of an in-cell 200 μM unphosphorylated β2 wt sample injected with 2 mM 14-3-3-ζ; the interaction is weak, in
the millimolar range, and an accurate fit could not be obtained. (b) ITC sensorgram of an in-cell 120 μM β2-45pT
phospho-peptide injected with 1.2 mM 14-3-3-ζ; thermodynamic parameters from the fit are shown in Fig. 2e. (c) ITC
sensorgram of an in-cell 120 μM β2-11pT phospho-peptide injected with 1.2 mM 14-3-3-ζ. (d) Sequence alignment of
β-integrin tails used in this study with residues colored depending on amino acid type (blue for basic, red for acid, purple for
aromatic, black for aliphatic, green for polar and yellow for Gly and Pro residues). Asterisks, colons and dots indicate the
degree of conservation. Residues identical with β1A in equivalent positions are indicated with dots.
3068 14-3-3-ζ Interactions with Integrin Tailsinteractions are weak and they are sensitive to
secondary effects, for example, modulation of local
concentration by sequestration of partners close to
the plasma membrane.
Although the 14-3-3 interactions detected here are
weak, many specific biologically relevant interac-
tions of similar magnitude are known, for example,
talin/β-integrin tail interactions.3 Presumably these
affinities are tuned to be sensitive to modulation of
local concentrations in the cell.42,43 Studies of these
weak interactions are often contradictory because
interactions detected by some methods, such as
yeast two-hybrid and pull-down experiments with
fusion proteins, are no longer detected when purified
reagents and biophysical methods are applied.
It has been proposed that 14-3-3-β regulates
integrin-mediated cell adhesion by a FAK-indepen-
dent mechanism.21 Other studies reported that the
absence of 14-3-3-ζ inhibited integrin-induced Rac1
activation and cell spreading and that these pro-
cesses were compromised by a 14-3-3-ζ S58D
variant.44,45 Our results with 14-3-3-ζ S58 variants
are consistent with these findings and highlight therole of S58 in mediating 14-3-3-ζ interactions with
integrins.
In conclusion, the crystal structure of an α-integrin
cytoplasmic tail in complex with 14-3-3-ζ together
with detailed biophysical studies have shown that,
while many structural features are similar to other
known 14-3-3 complexes, the binding exhibits subtle
features involving secondary sites. We have also
shown that 14-3-3-ζ is a general binder of β-integrin
tails, with a preference for β1A, and that β2 contains
two independent, non-overlapping 14-3-3-ζ binding
sites. Questions beyond the scope of this work will
be key for future studies: what is the physiological
role of 14-3-3/integrin tail interactions; how do
properties and affinities of the various 14-3-3/integrin
tail complexes relate to different aspects of cell
biology; the determination of the structure of a
14-3-3/unphosphorylated β-integrin tail complex
would also provide valuable information about the
molecular details of the novel β-integrin tail interac-
tion we reported and whether this is likely to be
involved in competition with talin in the process of
integrin activation.
Fig. 6. Fluorescence polarization and ITC of interactions between integrin tails and 14-3-3-ζ. (a) Fluorescence
polarization titrations of fluorescein-labeled β1A, β3 and α4 with 14-3-3-ζ. No binding was detected for β3 and α4, but β1A
clearly binds. The β1A titration was fitted to a single-site model as described elsewhere,37 with a value of Kd = 95 ±
16 μM. (b–d) ITC sensorgram of an in-cell 200 μM β1A, β2 (same as in Fig. 5a) or β3 samples injected with 2 mM 14-3-3-ζ.
Only β1A gave a binding curve that could be fitted with Kd = 280 ± 40 μM.
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Protein expression and purification
Integrin cytoplasmic tails were cloned into a modified
pET16b vector with an N-terminal His10 tag followed by a
3C protease cleavage site and the required integrin tail
sequence and expressed in Escherichia coli BL21 (DE3)
with 0.5 mM IPTG overnight at 37 °C. M9 minimal media
containing 15NH4Cl and
13C glucose were used to prepare
labeled integrin tails. The proteins were purified under
denaturing conditions [50 mM sodium phosphate, 150 mM
NaCl, 8 M urea and 0.035% β-mercaptoethanol (pH 7.0)]
by Co2+ affinity resin (Thermo Scientific) eluting with
200 mM imidazole. Samples were then dialyzed against
50 mM sodium phosphate, 150 mM NaCl, 1 mM ethyle-
nediaminetetraacetic acid and 1 mMDTT, cleaved with 3C
protease at 4 °C and further purified by reverse phase
HPLC using a C18 column (Jupiter).14-3-3-ζ was expressed from the same pET16b vector
in an analogous manner (0.5 mM IPTG, 20 °C incubation).
Cells were harvested by centrifugation; resuspended in
50 mM sodium phosphate, 150 mM NaCl and 0.035%
β-mercaptoethanol (pH 7.0); and disrupted by sonication.
The soluble fraction was purified by Co2+ affinity chroma-
tography, cleaved to remove the His10 tag and further
purified by size-exclusion chromatography in NMR buffer
[20 mM sodium phosphate and 50 mM NaCl (pH 6.5)],
using a Superdex75 column (GE Healthcare).
Integrin tail and 14-3-3-ζ mutants were generated
according to the QuikChange site-directed mutagenesis
protocol (Stratagene) and produced and purified in the
same way as wt proteins.
NMR spectroscopy
Samples were prepared in NMR buffer (pH 6.5) with 5%
D2O, and experiments were performed at 25 °C. Titration
3070 14-3-3-ζ Interactions with Integrin Tailsexperiments were collected on a 500-MHz spectrometer
using a water flip-back-embedded gradient enhanced
15N–1H HSQC pulse sequence.46 For the assignment of
the α4 and β2 backbone resonances, 15N–13C integrin tails
of 0.6 mM concentration were used to measure CBCA(CO)
NH and CBCANH experiments on a Bruker 500-MHz
instrument equipped with a cryogenic probe head. Data
were processed using NMRPipe47 and analyzed with the
programs CARA/XEASY48 or CCPN Analysis.49ITC and fluorescence polarization
Phosphorylated α4 synthetic peptides were purchased
fromGLBiochemLtd. (Shanghai). All recombinant proteins
and synthetic peptides were prepared in 20 mM sodium
phosphate and 50 mM NaCl (pH 6.5), and concentrations
were determined by UV absorbance at 280 nm. ITC
experiments using a VP-ITC200 instrument (MicroCal)
were performed at 298 K as follows: the cell (volume,
~200 μl) contained the different integrin tail fragments, and
the syringe (volume, ~40 μl) contained 14-3-3-ζ. A first
injection of 2 μl was followed by 15 injections of 2.5 μl, with
a stirring speed of 1500 rpmand a delay between injections
of 180 s. A blank titration was performed by injecting
14-3-3-ζ into buffer to take the heat of dilution into account.
Experiments were repeated twice for each sample. Raw
data were processed and fitted with MicroCal Origin
software using a one-site model where the error function
is calculated as the sum of the squared deviations between
the data and the model curve.
For fluorescence polarization experiments, integrin tails
were labeledwith fluorescein-5-maleimide (Invitrogen) linked
to an engineered C-terminal Cys residue. Measurements
were performed using 96-well microplates (Corning) in a
PHERAstar FS microplate reader (BMG Labtech). Fluor-
escein-labeled integrin tails at 1 μM concentration were
excited at 485 nm, and polarization was recorded at 520 nm.Crystallization, data collection and structure
determination
Samples for crystallization trials contained 10 mg/ml
(0.35 mM) 14-3-3-ζ and 2.6 mg/ml (0.7 mM) α4-30pS
peptide in 20 mM Tris–HCl and 50 mM NaCl (pH 7.5).
Crystals were grown by the sitting-drop vapor diffusion
method at 4 °C using 1:1 ratios of sample and 0.1 M Na
Hepes (pH 7.5) and 25% polyethylene glycol 2000
monomethyl ether mother liquor. For data collection,
crystals were soaked in the same buffer plus 15% glycerol
and flash frozen in liquid nitrogen.
Data were collected at the Diamond Light Source
beamline I04-1; the diffraction data extended to 2.2 Å
resolution. Data were indexed and integrated using
MOSFLM and merged using SCALA from the CCP4
program suite.50 A subset of approximately 5% of total
reflections were flagged for use in calculating Rfree. Initial
structure determination was performed by molecular
replacement using Phaser51 with Protein Data Bank
entry 2O0252 as the search model. Initial refinement
was performed with PHENIX,28 model building was
performed with Coot53 and subsequent refinement was
performed with BUSTER.54 The structure refined to a
satisfactory Rwork/Rfree, and the quality of the structurewas assessed using MolProbity.55 Omit maps were
calculated using PHENIX.28 Table 2 provides the crys-
tallographic data and refinement statistics. PyMOL56 and
the PISA server from European Bioinformatics Institute31
were used to analyze the structure and prepare the
structural figures.
Accession codes
Atomic coordinates for the 14-3-3-ζ/α4 phosphorylated
peptide complex have been deposited in the Protein Data
Bank under accession number 4HKC, and chemical shift
resonance assignments for the α4 and β2 integrin
cytoplasmic domains have been deposited in the Biolog-
ical Magnetic Resonance Bank under accession numbers
18718 and 18719.
Supplementary data to this article can be found online at
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